Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Gut

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 14.3%GRADE not reported 0 · 0%Very low 3 · 42.9%Low 1 · 14.3%Moderate 2 · 28.6%High 0 · 0%

Web‐based disease monitoring vs sham monitoring

Flare‐ups or relapse (continuous) · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Telephone‐based disease monitoring vs face‐to‐face monitoring

Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease

It is very uncertain whether telephone‐based disease monitoring changes flare‐ups/relapse (dichotomous; adults) compared with face‐to‐face monitoring (very low certainty).

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
RR 1.17 [0.47, 2.89]
1 study · 42 participants
Very low

Telephone‐based disease monitoring vs face‐to‐face monitoring

Flare‐ups/relapse (dichotomous; children) · people with inflammatory bowel disease

It is very uncertain whether telephone‐based disease monitoring changes flare‐ups/relapse (dichotomous; children) compared with face‐to‐face monitoring (very low certainty).

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
RR 0.24 [0.03, 2.05]
1 study · 86 participants
Very low

Web‐based disease monitoring vs usual care

Flare‐ups or relapse (continuous) · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 909 participants
Moderate

Web‐based disease monitoring vs self‐screening

Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 102 participants
Very low

Web‐based disease monitoring vs usual care

Flare‐ups/relapse (dichotomous; adults) · people with inflammatory bowel disease

Web‐based disease monitoring showed no clear difference in flare‐ups/relapse (dichotomous; adults) compared with usual care (moderate certainty).

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
RR 1.09 [0.93, 1.27]
5 studies · 868 participants
Moderate

Web‐based disease monitoring vs usual care

Flare‐ups/relapse (dichotomous; children) · people with inflammatory bowel disease

Web‐based disease monitoring showed no clear difference in flare‐ups/relapse (dichotomous; children) compared with usual care (low certainty).

1 finding from 1 review

Remote care through telehealth for people with inflammatory bowel disease 2023 · Cochrane Headline outcomes only
RR 0.99 [0.65, 1.51]
1 study · 170 participants
Low